Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-dried formats, granulated minerals, and triturated blends to meet the needs across functional foods, dietary supplements, infant and clinical nutrition, fast-moving consumer goods, and convenience food formulations. In addition, the company is involved in manufacturing, developing, buying, selling, importing, exporting, trading, agency, testing, distributing, consigning, stocking, registering, packing, marketing, refining, and processing of pharmaceu
| Current Price | ₹962.00 |
|---|---|
| Market Cap | ₹11,303 Cr |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Excipients and Mineral Actives |
| P/E Ratio | 64.8 |
| Return on Equity | 19.41% |
| 52-Week Range | ₹524.05 – ₹1,378.00 |
| Beta (1Y) | 0.49 |
| Dividend Yield | 0.15% |
| Revenue | ₹158 Cr |
|---|---|
| Net Profit | ₹41 Cr |
| EPS (Basic) | ₹3.59 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Pharmaceutical, Food and Nutrition-56.5% 2. Specialty Ingredients-43.5%
Sudeep Pharma Limited is trading at ₹962.00, with a market capitalisation of ₹11,303 Cr.
Sudeep Pharma Limited operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Excipients and Mineral Actives).
Sudeep Pharma Limited has a P/E of 64.8 and a return on equity of 19.41%.
In Q1 FY27, Sudeep Pharma Limited reported revenue of ₹158 Cr and net profit of ₹41 Cr, with basic EPS of ₹3.59 (consolidated, parsed from the company's exchange filing).